tiprankstipranks
Veeva price target raised to $195 from $183 at Morgan Stanley
The Fly

Veeva price target raised to $195 from $183 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Veeva (VEEV) to $195 from $183 and keeps an Underweight rating on the shares. Diversified Managed Care “woefully underperformed” in 2024 and while uncertainty is pressuring sentiment, the firm sees “opportunities in a friendlier policy backdrop,” the analyst tells investors in a 2025 outlook note on the healthcare services group. Among Healthcare Technology and Providers, the firm remains selective due to mixed demand and policy uncertainties, the analyst added.

Pick the best stocks and maximize your portfolio:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App